A large-scale study of two first-line treatments for HIV-infected children shows that the less-used regimen is more effective in suppressing the virus, paving the way for changing the standard of care provided to infected children in sub-Saharan Africa, where the virus is most prevalent.
Researchers from The Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of